In order to confirm the potential impact of circulating IL-6 for plasma-NGAL levels found in septic patients and patients with rheumatic disease after treatment with an anti-TNF agent, whole blood samples were stimulated with IL-6. The gene discussed is IL6; the disease is rheumatic disorder.